CINF
53
3
LLY
28
-8
FOX
51
-6
PYPL
52
-2
CMS
60
2
MCO
71
-7
C
62
4
AXP
67
-2
FRT
41
-2
CRM
60
-7
UPS
48
2
TXT
53
-3
VRSN
53
-5
IPG
34
-9
STI
45
26
REGN
38
-2
DVN
14
-6
DE
42
3
WM
74
-5
TDC
67
-4
CINF
53
3
LLY
28
-8
FOX
51
-6
PYPL
52
-2
CMS
60
2
MCO
71
-7
C
62
4
AXP
67
-2
FRT
41
-2
CRM
60
-7
UPS
48
2
TXT
53
-3
VRSN
53
-5
IPG
34
-9
STI
45
26
REGN
38
-2
DVN
14
-6
DE
42
3
WM
74
-5
TDC
67
-4
Financhill
Back

Apellis Pharmaceuticals Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
33

APLS
Apellis Pharmaceuticals

Last Price:
26.19
Seasonality Move:
20.78%
Buy
55

EYPT
EyePoint Pharmaceuticals

Last Price:
8.60
Seasonality Move:
27.28%
Sell
33
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $26.27. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $9.17. The Score for EYPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $26.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $9.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 36.3 Sell
Chaikin Money Flow: -4148679 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.02 - 28.78) Sell
Bollinger Bands (100): (29.08 - 39.08) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.24 Buy
Relative Strength Index (14 RSI): 38.26 Sell
Chaikin Money Flow: -855119 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.95 - 11.87) Sell
Bollinger Bands (100): (8.09 - 10.47) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.63 Sell
20-day SMA: 27.95 Sell
50-day SMA: 30.19 Sell
200-day SMA: 43.29 Sell
8-day EMA: 28.09 Sell
20-day EMA: 28.31 Sell
50-day EMA: 30.23 Sell
200-day EMA: 40.03 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.1 Sell
20-day SMA: 11.08 Sell
50-day SMA: 9.67 Sell
200-day SMA: 14.04 Sell
8-day EMA: 10.73 Sell
20-day EMA: 10.79 Sell
50-day EMA: 10.16 Sell
200-day EMA: 11.6 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):